<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851641</url>
  </required_header>
  <id_info>
    <org_study_id>CEN_2015_9</org_study_id>
    <nct_id>NCT02851641</nct_id>
  </id_info>
  <brief_title>Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children</brief_title>
  <acronym>CANALHEMO</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the risk in intra-operative nasal hemorrhage when using a
      &quot;pushed&quot; probe (Master Ka) in the treatment of naso lacrimal duct obstruction (NLDO).

      In the investigator's experience, this risk seemed to minus using a pushed probe rather than
      the classical pulled-type probes.

      A lower risk of hemorrhage could lead to a change in the anesthetic procedure. The gold
      standard in NLDO is the use of an orotracheal intubation. It could then be replaced by the
      use of an orolaryngeal mask. A forthcoming study will evaluate the results of this anesthetic
      change.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2, 2015</start_date>
  <completion_date type="Actual">December 10, 2019</completion_date>
  <primary_completion_date type="Actual">September 11, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal hemorrhage</measure>
    <time_frame>Through surgery completion, an average of 1 hour</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Lacrimal Duct Obstruction</condition>
  <arm_group>
    <arm_group_label>Nasolacrimal duct obstruction</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>&quot;pushed&quot; mono-canaliculonasal intubation</intervention_name>
    <arm_group_label>Nasolacrimal duct obstruction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with congenital nasolacrimal duct obstruction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 6 years of age

          -  Unilateral lacrimal duct obstruction with programmed surgery

          -  Surgery scheduled wih a &quot;pushed&quot; mono-canaliculonasal intubation

          -  No opposition of parents for he participation of their child

        Exclusion Criteria:

          -  Coagulation disorder

          -  Previous history of nasolacrimal intubation (homo or contra-lateral)

          -  Non covered by health insurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmologique A. de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2016</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lacrimal Duct Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

